BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Darin N, Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord. 2000;10:1-9. [PMID: 10677857 DOI: 10.1016/s0960-8966(99)00055-3] [Cited by in Crossref: 110] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Stridh M, Ekström A, Kroksmark A. Postural control in the congenital and childhood forms of myotonic dystrophy type 1. European Journal of Physiotherapy 2017;19:24-31. [DOI: 10.1080/21679169.2016.1229028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Pagola-Lorz I, Vicente E, Ibáñez B, Torné L, Elizalde-Beiras I, Garcia-Solaesa V, García F, Delfrade J, Jericó I. Epidemiological study and genetic characterization of inherited muscle diseases in a northern Spanish region. Orphanet J Rare Dis 2019;14:276. [PMID: 31791368 DOI: 10.1186/s13023-019-1227-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Edinoff AN, Nguyen LH, Odisho AS, Maxey BS, Pruitt JW, Girma B, Cornett EM, Kaye AM, Kaye AD. The Antisense Oligonucleotide Nusinersen for Treatment of Spinal Muscular Atrophy. Orthop Rev (Pavia) 2021;13:24934. [PMID: 34745470 DOI: 10.52965/001c.24934] [Reference Citation Analysis]
4 Mhatre R, Sekar D, Ponmalar J, Nagappa M, Veeramani PK, Polavarapu K, Vengalil S, Atchayaram N, Narayanappa G. Utility of Immunohistochemistry and Western Blot in Profiling Clinically Suspected Cases of Congenital Muscular Dystrophy. Ann Indian Acad Neurol 2021;24:198-203. [PMID: 34220063 DOI: 10.4103/aian.AIAN_18_20] [Reference Citation Analysis]
5 Tehrani KHN, Hajiloo M, Asadollahi E, Lagini FP. Prevalence of muscular dystrophy in patients with muscular disorders in Tehran, Iran. Eur J Transl Myol 2018;28:7380. [PMID: 29991987 DOI: 10.4081/ejtm.2018.7385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Witting N, Werlauff U, Duno M, Vissing J. Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark. Neurol Genet. 2017;3:e140. [PMID: 28357410 DOI: 10.1212/nxg.0000000000000140] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
7 Mohamadian M, Rastegar M, Pasamanesh N, Ghadiri A, Ghandil P, Naseri M. Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview. J Mol Neurosci 2021. [PMID: 34727324 DOI: 10.1007/s12031-021-01933-4] [Reference Citation Analysis]
8 Huang K, Bi FF, Yang H. A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy. Front Neurol 2021;12:761636. [PMID: 34795634 DOI: 10.3389/fneur.2021.761636] [Reference Citation Analysis]
9 Telfer WR, Nelson DD, Waugh T, Brooks SV, Dowling JJ. Neb: a zebrafish model of nemaline myopathy due to nebulin mutation. Dis Model Mech 2012;5:389-96. [PMID: 22159874 DOI: 10.1242/dmm.008631] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
10 Nassoro DD, Torres L, Marando R, Mboma L, Mushi S, Habakkuk Mwakyula I. A child with duchenne muscular dystrophy: A case report of a rare diagnosis among Africans. Clin Case Rep 2020;8:2654-60. [PMID: 33363799 DOI: 10.1002/ccr3.3254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Miller LA, Romitti PA, Cunniff C, Druschel C, Mathews KD, Meaney FJ, Matthews D, Kantamneni J, Feng ZF, Zemblidge N, Miller TM, Andrews J, Fox D, Ciafaloni E, Pandya S, Montgomery A, Kenneson A. The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology. Birth Defects Res A Clin Mol Teratol 2006;76:793-7. [PMID: 17036307 DOI: 10.1002/bdra.20279] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
12 Jungbluth H. Multi-minicore Disease. Orphanet J Rare Dis 2007;2:31. [PMID: 17631035 DOI: 10.1186/1750-1172-2-31] [Cited by in Crossref: 88] [Cited by in F6Publishing: 68] [Article Influence: 5.9] [Reference Citation Analysis]
13 Graziano A, Bianco F, D'Amico A, Moroni I, Messina S, Bruno C, Pegoraro E, Mora M, Astrea G, Magri F, Comi GP, Berardinelli A, Moggio M, Morandi L, Pini A, Petillo R, Tasca G, Monforte M, Minetti C, Mongini T, Ricci E, Gorni K, Battini R, Villanova M, Politano L, Gualandi F, Ferlini A, Muntoni F, Santorelli FM, Bertini E, Pane M, Mercuri E. Prevalence of congenital muscular dystrophy in Italy: a population study. Neurology 2015;84:904-11. [PMID: 25653289 DOI: 10.1212/WNL.0000000000001303] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 5.6] [Reference Citation Analysis]
14 Zhang Y, Mann JR, James KA, McDermott S, Conway KM, Paramsothy P, Smith T, Cai B; MD STARnet. Duchenne and Becker Muscular Dystrophies' Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences. Neuroepidemiology 2021;55:47-55. [PMID: 33477152 DOI: 10.1159/000512647] [Reference Citation Analysis]
15 Romitti PA, Zhu Y, Puzhankara S, James KA, Nabukera SK, Zamba GK, Ciafaloni E, Cunniff C, Druschel CM, Mathews KD, Matthews DJ, Meaney FJ, Andrews JG, Conway KM, Fox DJ, Street N, Adams MM, Bolen J; MD STARnet. Prevalence of Duchenne and Becker muscular dystrophies in the United States. Pediatrics 2015;135:513-21. [PMID: 25687144 DOI: 10.1542/peds.2014-2044] [Cited by in Crossref: 109] [Cited by in F6Publishing: 95] [Article Influence: 15.6] [Reference Citation Analysis]
16 Barraza-Flores P, Hermann HJ, Bates CR, Allen TG, Grunert TT, Burkin DJ. Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD. Skelet Muscle 2020;10:18. [PMID: 32498713 DOI: 10.1186/s13395-020-00235-4] [Reference Citation Analysis]
17 Desguerre I, Laugel V. Diagnostic et histoire naturelle de la dystrophie musculaire de Duchenne. Archives de Pédiatrie 2015;22:12S24-30. [DOI: 10.1016/s0929-693x(16)30005-7] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Aring E, Ekström AB, Tulinius M, Sjöström A. Ocular motor function in relation to gross motor function in congenital and childhood myotonic dystrophy type 1. Acta Ophthalmol 2012;90:369-74. [PMID: 20560889 DOI: 10.1111/j.1755-3768.2010.01956.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
19 Holmberg J, Durbeej M. Laminin-211 in skeletal muscle function. Cell Adh Migr 2013;7:111-21. [PMID: 23154401 DOI: 10.4161/cam.22618] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 7.2] [Reference Citation Analysis]
20 Wahlgren L, Kroksmark AK, Tulinius M, Sofou K. One in five patients with Duchenne muscular dystrophy dies from other causes than cardiac or respiratory failure. Eur J Epidemiol 2021. [PMID: 34802091 DOI: 10.1007/s10654-021-00819-4] [Reference Citation Analysis]
21 Langer S, Rudnik-schöneborn S, Zerres K, Grimm T. Genetisches Modell der autosomal-rezessiv erblichen proximalen spinalen Muskelatrophie. Medizinische Genetik 2013;25:337-46. [DOI: 10.1007/s11825-013-0402-z] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132:3175-3186. [PMID: 19767415 DOI: 10.1093/brain/awp236] [Cited by in Crossref: 296] [Cited by in F6Publishing: 261] [Article Influence: 22.8] [Reference Citation Analysis]
23 Moegle C, Severac F, Lipsker D. Epidemiology of juvenile dermatomyositis in Alsace. Br J Dermatol 2020;182:1307-8. [PMID: 31823358 DOI: 10.1111/bjd.18799] [Reference Citation Analysis]
24 Bertini E, D'Amico A, Gualandi F, Petrini S. Congenital muscular dystrophies: a brief review. Semin Pediatr Neurol 2011;18:277-88. [PMID: 22172424 DOI: 10.1016/j.spen.2011.10.010] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
25 Salari N, Fatahi B, Valipour E, Kazeminia M, Fatahian R, Kiaei A, Shohaimi S, Mohammadi M. Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis. J Orthop Surg Res 2022;17:96. [PMID: 35168641 DOI: 10.1186/s13018-022-02996-8] [Reference Citation Analysis]
26 Warmbrunn MV, de Bakker BS, Hagoort J, Alefs-de Bakker PB, Oostra RJ. Hitherto unknown detailed muscle anatomy in an 8-week-old embryo. J Anat 2018;233:243-54. [PMID: 29726018 DOI: 10.1111/joa.12819] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
27 Liao Q, Zhang Y, He J, Huang K. Global prevalence of myotonic dystrophy: an updated systematic review and meta-analysis. Neuroepidemiology 2022. [PMID: 35483324 DOI: 10.1159/000524734] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, Smith EC, McDonald CM, Zaidman CM, Morgenroth LP, Osaki H, Satou Y, Yamashita T, Hoffman EP; CINRG DNHS Investigators. Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping: A Phase 2 Randomized Clinical Trial. JAMA Neurol 2020;77:982-91. [PMID: 32453377 DOI: 10.1001/jamaneurol.2020.1264] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 32.0] [Reference Citation Analysis]
29 Jungbluth H. Central core disease. Orphanet J Rare Dis 2007;2:25. [PMID: 17504518 DOI: 10.1186/1750-1172-2-25] [Cited by in Crossref: 104] [Cited by in F6Publishing: 87] [Article Influence: 6.9] [Reference Citation Analysis]
30 Shinar S, Balakumar P, Shah V, Chong K, Uster T, Chitayat D. Fetal Macrocephaly: A Novel Sonographic Finding in Congenital Myotonic Dystrophy. AJP Rep 2020;10:e294-9. [PMID: 33133763 DOI: 10.1055/s-0040-1716742] [Reference Citation Analysis]
31 Engvall M, Sjögreen L, Kjellberg H, Robertson A, Sundell S, Kiliaridis S. Oral health status in a group of children and adolescents with myotonic dystrophy type 1 over a 4-year period. International Journal of Paediatric Dentistry 2009;19:412-22. [DOI: 10.1111/j.1365-263x.2009.01012.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
32 Stenzel W, Goebel HH, Bader-Meunier B, Gitiaux C. Inflammatory myopathies in childhood. Neuromuscul Disord 2021;31:1051-61. [PMID: 34736626 DOI: 10.1016/j.nmd.2021.08.007] [Reference Citation Analysis]
33 Douniol M, Jacquette A, Guilé JM, Tanguy ML, Angeard N, Héron D, Plaza M, Cohen D. Psychiatric and cognitive phenotype in children and adolescents with myotonic dystrophy. Eur Child Adolesc Psychiatry 2009;18:705-15. [PMID: 19543792 DOI: 10.1007/s00787-009-0037-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
34 Lawal TA, Todd JJ, Meilleur KG. Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches. Neurotherapeutics 2018;15:885-99. [PMID: 30406384 DOI: 10.1007/s13311-018-00677-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 12.7] [Reference Citation Analysis]
35 Arkblad E, Tulinius M, Kroksmark AK, Henricsson M, Darin N. A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy. Acta Paediatr 2009;98:865-72. [PMID: 19154529 DOI: 10.1111/j.1651-2227.2008.01201.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.7] [Reference Citation Analysis]
36 Petri H, Wahbi K, Witting N, Køber L, Bundgaard H, Kamoun E, Vellieux G, Stojkovic T, Béhin A, Laforet P, Vissing J. Congenital myopathies are mainly associated with a mild cardiac phenotype. J Neurol 2019;266:1367-75. [PMID: 30874888 DOI: 10.1007/s00415-019-09267-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Vieitez I, Gallano P, González-quereda L, Borrego S, Marcos I, Millán J, Jairo T, Prior C, Molano J, Trujillo-tiebas M, Gallego-merlo J, García-barcina M, Fenollar M, Navarro C. Mutational spectrum of Duchenne muscular dystrophy in Spain: study of 284 cases. Neurología (English Edition) 2017;32:377-85. [DOI: 10.1016/j.nrleng.2015.12.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
38 Ziyaee F, Shorafa E, Dastsooz H, Habibzadeh P, Nemati H, Saeed A, Silawi M, Farazi Fard MA, Faghihi MA, Dastgheib SA. A novel mutation in SEPN1 causing rigid spine muscular dystrophy 1: a Case report. BMC Med Genet 2019;20:13. [PMID: 30642275 DOI: 10.1186/s12881-018-0743-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Colombo I, Scoto M, Manzur AY, Robb SA, Maggi L, Gowda V, Cullup T, Yau M, Phadke R, Sewry C, Jungbluth H, Muntoni F. Congenital myopathies: Natural history of a large pediatric cohort. Neurology 2015;84:28-35. [PMID: 25428687 DOI: 10.1212/WNL.0000000000001110] [Cited by in Crossref: 71] [Cited by in F6Publishing: 28] [Article Influence: 8.9] [Reference Citation Analysis]
40 Kang PB, Morrison L, Iannaccone ST, Graham RJ, Bönnemann CG, Rutkowski A, Hornyak J, Wang CH, North K, Oskoui M, Getchius TS, Cox JA, Hagen EE, Gronseth G, Griggs RC; Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 2015;84:1369-78. [PMID: 25825463 DOI: 10.1212/WNL.0000000000001416] [Cited by in Crossref: 63] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
41 Jungbluth H, Wallgren-Pettersson C, Laporte J. Centronuclear (myotubular) myopathy. Orphanet J Rare Dis 2008;3:26. [PMID: 18817572 DOI: 10.1186/1750-1172-3-26] [Cited by in Crossref: 192] [Cited by in F6Publishing: 169] [Article Influence: 13.7] [Reference Citation Analysis]
42 Yang HM, Guo JX, Yang YM. Congenital fiber-type disproportion presenting with type II respiratory failure after delivery: A case report. World J Clin Cases 2021; 9(7): 1748-1754 [PMID: 33728321 DOI: 10.12998/wjcc.v9.i7.1748] [Reference Citation Analysis]
43 Bönnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, Muntoni F, Sewry C, Béroud C, Mathews KD, Moore SA, Bellini J, Rutkowski A, North KN; Members of International Standard of Care Committee for Congenital Muscular Dystrophies. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord 2014;24:289-311. [PMID: 24581957 DOI: 10.1016/j.nmd.2013.12.011] [Cited by in Crossref: 189] [Cited by in F6Publishing: 158] [Article Influence: 23.6] [Reference Citation Analysis]
44 Landfeldt E, Sejersen T, Tulinius M. A mini-review and implementation model for using ataluren to treat nonsense mutation Duchenne muscular dystrophy. Acta Paediatr 2019;108:224-30. [PMID: 30188594 DOI: 10.1111/apa.14568] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
45 Barroso de Queiroz Davoli G, Bartels B, Mattiello-Sverzut AC, Takken T. Cardiopulmonary exercise testing in neuromuscular disease: a systematic review. Expert Rev Cardiovasc Ther 2021;19:975-91. [PMID: 34826261 DOI: 10.1080/14779072.2021.2009802] [Reference Citation Analysis]
46 Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, Cook SF, Lochmüller H. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis 2017;12:124. [PMID: 28676062 DOI: 10.1186/s13023-017-0671-8] [Cited by in Crossref: 162] [Cited by in F6Publishing: 146] [Article Influence: 32.4] [Reference Citation Analysis]
47 Müller KI, Ghelue MV, Lund I, Jonsrud C, Arntzen KA. The prevalence of hereditary neuromuscular disorders in Northern Norway. Brain Behav 2021;11:e01948. [PMID: 33185984 DOI: 10.1002/brb3.1948] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Crisafulli S, Sultana J, Fontana A, Salvo F, Messina S, Trifirò G. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis 2020;15:141. [PMID: 32503598 DOI: 10.1186/s13023-020-01430-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
49 Magee L, Bram JT, Anari JB, Ramo B, Mayer OH, Matsumoto H, Brooks JT, Andras L, Lark R, Fitzgerald R, Truong W, Li Y, Karlin L, Schwend R, Weinstein S, Roye D, Snyder B, Flynn JM, Oetgen M, Smith J, Cahill PJ; PSSG. Outcomes and Complications in Management of Congenital Myopathy Early-Onset Scoliosis. J Pediatr Orthop 2021;41:531-6. [PMID: 34325442 DOI: 10.1097/BPO.0000000000001922] [Reference Citation Analysis]
50 Köhler C, Weigt-usinger K, Heyer C, Thiels C, Dekomien G, Vorgerd M, Lücke T. CNS findings in congenital muscular dystrophy 1A (with laminin alpha-2-deficiency). Translational Neuroscience 2011;2. [DOI: 10.2478/s13380-011-0020-7] [Reference Citation Analysis]
51 Borisovna KO, Yurievna KA, Yurievich TK, Igorevna KO, Olegovich KD, Igorevna DA, Timofeevna BT, Vyacheslavovna ZN, Ivanovna SE, Alekseevich SP, Vladimirovich IV. Compound heterozygous POMGNT1 mutations leading to muscular dystrophy-dystroglycanopathy type A3: a case report. BMC Pediatr 2019;19:98. [PMID: 30961548 DOI: 10.1186/s12887-019-1470-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]